165 related articles for article (PubMed ID: 34321931)
1. Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers.
Jahnsen JA; Widnes SF; Schjøtt J
Drug Healthc Patient Saf; 2021; 13():151-157. PubMed ID: 34321931
[TBL] [Abstract][Full Text] [Related]
2. Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres.
Jahnsen JA; Widnes SF; Schjøtt J
Int Breastfeed J; 2018; 13():1. PubMed ID: 29339968
[TBL] [Abstract][Full Text] [Related]
3. Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.
Schjøtt J; Erdal H
BMC Complement Altern Med; 2014 Feb; 14():56. PubMed ID: 24529279
[TBL] [Abstract][Full Text] [Related]
4. Physicians' questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010-2015.
Schjøtt J
Aging Clin Exp Res; 2018 Jul; 30(7):867-870. PubMed ID: 28929445
[TBL] [Abstract][Full Text] [Related]
5. Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.
Schjøtt J; Bergman J
Drug Healthc Patient Saf; 2014; 6():89-92. PubMed ID: 25061339
[TBL] [Abstract][Full Text] [Related]
6. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
Chiappini S; Schifano F
J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
[TBL] [Abstract][Full Text] [Related]
7. Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS).
Stokes CL; Schjøtt J
Eur J Clin Pharmacol; 2019 Oct; 75(10):1469-1470. PubMed ID: 31300837
[No Abstract] [Full Text] [Related]
8. A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study.
Schjøtt J; Reppe LA; Roland PD; Westergren T
BMJ Open; 2012; 2(2):e000642. PubMed ID: 22422916
[TBL] [Abstract][Full Text] [Related]
9. Review of Clinical Questions Submitted to Norwegian Drug Information Centres Concerning Administration and Dosage to Older Patients of Relevance to Patient-Centric Care.
Schjøtt J; Andreassen LM; Dale GH; Stokes CL
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33466963
[TBL] [Abstract][Full Text] [Related]
10. The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015.
Gjerden P; Bramness JG; Tvete IF; Slørdal L
Eur J Clin Pharmacol; 2017 Sep; 73(9):1173-1179. PubMed ID: 28623386
[TBL] [Abstract][Full Text] [Related]
11. Healthcare professionals' information need related to antiseizure medication use in breastfeeding patients with epilepsy. Retrospective analysis of enquiries to Norwegian medicines information and pharmacovigilance centers.
Reitan Riibe S; Heitmann K; Schjøtt J; Riedel B
Epilepsy Behav Rep; 2023; 24():100629. PubMed ID: 37954010
[TBL] [Abstract][Full Text] [Related]
12. Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
Bakkebø T; Widnes SF; Aamlid SS; Schjøtt J
Clin Ther; 2016 May; 38(5):1102-8. PubMed ID: 26973297
[TBL] [Abstract][Full Text] [Related]
13. Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.
Schjøtt J
EPMA J; 2019 Jun; 10(2):109-114. PubMed ID: 31258816
[TBL] [Abstract][Full Text] [Related]
14. Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics.
Montebello ME; Brett J
Curr Top Behav Neurosci; 2017; 34():125-139. PubMed ID: 26695164
[TBL] [Abstract][Full Text] [Related]
15. Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.
Klein L; Bangh S; Cole JB
West J Emerg Med; 2017 Feb; 18(2):243-250. PubMed ID: 28210359
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior?
Kim S; Lee G; Kim E; Jung H; Chang J
J Res Pharm Pract; 2017; 6(1):12-15. PubMed ID: 28331860
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine for insomnia: A review of the literature.
Anderson SL; Vande Griend JP
Am J Health Syst Pharm; 2014 Mar; 71(5):394-402. PubMed ID: 24534594
[TBL] [Abstract][Full Text] [Related]
18. The toxicology and comorbidities of fatal cases involving quetiapine.
Pilgrim JL; Drummer OH
Forensic Sci Med Pathol; 2013 Jun; 9(2):170-6. PubMed ID: 23397562
[TBL] [Abstract][Full Text] [Related]
19. Safety of low doses of quetiapine when used for insomnia.
Coe HV; Hong IS
Ann Pharmacother; 2012 May; 46(5):718-22. PubMed ID: 22510671
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine Abuse Fourteen Years Later: Where Are We Now? A Systematic Review.
Vento AE; Kotzalidis GD; Cacciotti M; Papanti GD; Orsolini L; Rapinesi C; Savoja V; Calabrò G; Del Casale A; Piacentino D; Caloro M; Girardi P; Schifano F
Subst Use Misuse; 2020; 55(2):304-313. PubMed ID: 31573374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
